Been awhile since l have looked over here and on the surface the clinical trial announcement is progress...of sorts. Couple of quick things, the announcement is for the design only for a proposed trial, so a very long way to go and a few hurdles it would seem. Also if the clinical trial design did proceed and eventually this leads to some sort of commercial deal....what percentage of the strain does CGB actually own?
- Forums
- ASX - By Stock
- CGB
- Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS
Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS, page-24
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online